EligibleTrials

Randomised Evaluation of Sodium Dialysate Levels on Vascular Events

Recruiting · NCT02823821 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Sydney

View the official record on ClinicalTrials.gov →
Chronic kidney disease

Interventions studied

Default dialysate sodium concentration of 137mmol/lDefault dialysate sodium concentration of 140mmol/l

What this trial is about

This global study will assess the effect of randomising dialysis sites to one of two default dialysate sodium concentrations in current practice, 140mmol/l and 137mmol/l, on major cardiovascular events and death in patients receiving maintenance haemodialysis.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

60 locations listed.

Showing 60 of 264 listed sites. See the official record for the complete list.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.